Table 1 Novel positively associated biomarker genera for each body site. Weight of each biomarker is measured by the percentile of feature importance in RFC-global amongst biomarker OTUs of the same body site. Prevalence is the average number of samples that biomarker OTUs of a genus were found in across all body sites